The US Food and Drug Administration (FDA) has greenlit new COVID-19 boosters for both Moderna and Pfizer, marking a proactive step in the fight against rapidly spreading infections in the country. Concurrently, Moderna and Pfizer have announced that their updated COVID-19 vaccines show a robust response against the BA.2.86 subvariant, a mutated version of the coronavirus.
In an unprecedented move, Moderna, a biotech firm based in Massachusetts, USA, has struck a landmark deal with Chinese officials to research, develop and manufacture messenger RNA (mRNA) medicines in China.
In Asia, tetanus remains a significant health concern, this article delves into the nature of the disease, its symptoms, and the importance of vaccination to prevent its potentially devastating consequences.
Medical Channel Asia presents the weekly Asian medical news bulletin, bringing you essential healthcare news from across the region. This week, we cover palliative care in Singapore and more.
As Hong Kong experiences a sudden surge in flu cases following the removal of the mask mandate, children’s wards in public hospitals are struggling to cope, and a shortage of the antiviral drug Tamiflu has emerged. While the situation may appear concerning, there are steps that can be taken to manage the shortage and protect vulnerable populations.
This medical news article reports on two incidents where a clinic in Hong Kong administered expired COVID-19 vaccines to patients. The Department of Health has launched an investigation, suspended the clinic’s vaccination service, and provided advice to improve vaccine management procedures. No discomfort has been reported by affected individuals, and no re-vaccination is needed, according to local experts.
